ABI-1968

CAS No. 1626364-18-8

ABI-1968( —— )

Catalog No. M35982 CAS No. 1626364-18-8

ABI-1968 has antiviral and antitumor activity and can be used to study immune system diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1474 Get Quote
5MG 1613 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ABI-1968
  • Note
    Research use only, not for human use.
  • Brief Description
    ABI-1968 has antiviral and antitumor activity and can be used to study immune system diseases.
  • Description
    ABI-1968 has antiviral and antitumor activity and can be used to study immune system diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1626364-18-8
  • Formula Weight
    675.839
  • Molecular Formula
    C35H58N5O6P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N=C(N)NC2=C1N=CN2CCOCP(=O)(OCC=3C=CC=CC3)OCCOCCCCCCCCCCCCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ezurpimtrostat hydro...

    Ezurpimtrostat hydrochloride (GNS561 hydrochloride) is an orally available palmitoyl protein thioesterase-1 inhibitor with antifibrotic, antiviral, and anticancer effects that blocks cancer cell proliferation by interacting with palmitoyl protein thioesterase to inhibit late autophagy and dose-dependently increase lysosomal accumulation.

  • 3’-O-Methyladenosine

    3’-O-Methyladenosine is an antiviral compound with inhibitory activity against West Nile Virus and can be used for the treatment of viral infections.3’-O-Methyladenosine inhibits adenosine deaminase type VII with a Ki value of 493 μM.

  • Riamilovir

    Riamilovir is a broad-spectrum antiviral drug candidate.